Healthy Steps,
Into a Game

Digital content that responds to every step makes treadmill workouts fun — with left-right balance and rhythm analysis built in.

Works with any powered treadmill · Setup takes 10 seconds

OUR VISION

Connect WalkingwithDigital Technology
fora More Fun and Healthier Life

Walking, Made Into a Habit You Enjoy

Regular walking is the easiest way to build a healthy daily routine.

Gait heatmaps comparing a walk with no joint discomfort and a walk with a stiff knee joint

Visualized Gait Analysis at a Glance

Just walk on your treadmill and your steps become a single picture. On the left, a walk with no joint discomfort; on the right, the walk of someone with a stiff knee joint.

PRODUCT INTRO

A sensing device
that can precisely capture
real-time Gait data

JAWS is a compact, easily deployable adapter that captures and analyzes gait data by precisely measuring real-time power consumption from electric treadmills.

*Upcoming design preview

HOW IT WORKS

Analyze Your Gait in 4 Simple Steps

step 1 image: [object Object],[object Object],[object Object],[object Object]

Connect Adapter to Treadmill

Connect the JAWS adapter to your treadmill.

step 2 image: [object Object],[object Object],[object Object],[object Object]

Connect to App via Bluetooth

step 3 image: [object Object],[object Object],[object Object],[object Object]

View Real-time Gait Graph and Enjoy Content

View your real-time gait graph during exercise. Also, the character responds to your movements in game mode.

step 4 image: [object Object],[object Object],[object Object],[object Object]

Check Your Gait Data After Workout

After your workout, review your gait data with visualizations and detailed analysis.

Elegaiter Updates

2026-09-20

Elegaiter Proves Value at 'PCA KOREA SUPER SERIES'

The 'PCA KOREA SUPER SERIES', one of the largest fitness competitions in South Korea, was successfully held over two days from September 19th to 20th. During the event, our Elegaiter team co-operated the 'Elegaiter Gait Analysis Booth' in collaboration with 'Joabro Conditioning'. It was a deeply meaningful opportunity to directly connect with fitness professionals and experts—the primary target audience for our product—and listen closely to their vivid, firsthand voices. This field participation was particularly significant as it allowed us to identify the critical need among fitness center operators for increasing the average sales per customer (unit price), while offering a clear, data-driven solution. By shifting away from traditional methods that rely heavily on a trainer's subjective assessment, Elegaiter visualizes and proves a member's movements through quantitative data. This experience has strengthened our confidence that fitness centers can successfully market their programs as premium services. Numerous industry insiders who visited our booth deeply resonated with the necessity of data-driven consultation and expressed overwhelming interest. While continuously advancing Elegaiter, our proprietary AIoT-based digital gait healthcare service, CiKLux is also preparing for the upcoming Wadiz crowdfunding campaign set to open at the end of September. As a special reward, we plan to provide close, customized support for the initial backers by implementing the specific gait analysis features and service developments they desire over a three-month period. Moving forward, we remain committed to technological innovation that listens to the voices on the ground, establishing ourselves as the most reliable partner growing alongside the fitness and healthcare industries. Thank you.

2026-09-16

CEO Invited as an Official Lecturer at 'Biohealth Academy'

## [Company News] CEO Hyun-sang Cho Invited as an Official Lecturer at the Chungbuk Bio-humanities and Academic Convergence Institute's 'Biohealth Academy' From September 16th to 17th, the ‘Biohealth Regulation and Licensing Practical Training: Clinical Trial Design and Major Considerations for Commercializing Pharmaceuticals, Medical Devices, and Digital Medical Products’ course was successfully conducted as part of the 'Biohealth Academy' program hosted by the Chungbuk Bio-humanities and Academic Convergence Institute. For this training course, Hyun-sang Cho, CEO of CiKLux, was invited as an official lecturer to pass down in-depth practical know-how to biohealth majors and prospective job seekers looking to enter the industry. CEO Hyun-sang Cho focused heavily on clinical trial design strategies indispensable for successfully commercializing not only conventional pharmaceuticals and medical devices but also digital medical products—a major hot topic in the current market. Rather than leaning on abstract theories, he generously shared core field-driven considerations that can be applied immediately in the industry, receiving highly enthusiastic responses from the trainees. Trainees who participated in the session sent expressions of gratitude, stating, "Being exposed to such specific, professional guides that can be put to work right in the field was incredibly helpful for our future career development." We send our most sincere encouragement to all the trainees who are passionately undergoing this extensive training curriculum to become the next leaders of the biohealth industry. We genuinely bless each of you, hoping that the knowledge and practical wisdom gained during these two days will serve as a fertile foundation to achieve your dreams and grow into brilliant assets to the bio sector. CiKLux develops its proprietary AIoT-based gait digital healthcare service, Elegaiter, while simultaneously taking dedicated steps to nurture global and domestic clinical trial experts, providing unsparing support so that our industry and its members can grow together. We will continue to be a dependable partner, advancing alongside the bio and healthcare industries through professional knowledge sharing and continuous technological innovation. Thank you.

2026-09-15

CEO Takes the Stage! '2026 NextBio Scale-up Academy'

Hyun-sang Cho, CEO of CiKLux, was invited as a keynote speaker and delivered a lecture at the '2026 NextBio Scale-up Academy (BioBiz Jumpstart)' on September 15. In this program designed to support the growth of startups in the bio and medical sectors, CEO Cho presented on the topic of "Understanding the Full Lifecycle of Digital Healthcare Development." The lecture provided a clear overview of core practical processes that digital healthcare companies frequently find challenging, including product planning, software (SW) development, SaMD (Software as a Medical Device) classification, clinical validity verification using algorithms and RWE (Real-World Evidence), and regulatory approval procedures. CEO Cho is a recognized clinical trial expert who continuously leads educational sessions for various specialized institutions, including clinical training programs for the Korea National Enterprise for Clinical Trials (KONECT). His lecture at this event once again demonstrated CiKLux’s industry-leading expertise, drawing significant engagement from biotech professionals in attendance. 'Elegaiter', the gait analysis and exercise solution service currently being advanced by the CiKLux team, is being developed based on this comprehensive expertise that spans from initial clinical planning to validation and regulatory approval. Leveraging its specialized technical capabilities and industry knowledge, CiKLux plans to further refine Elegaiter's features to deliver a highly sophisticated service to the clinical trial market. We look forward to the continued interest and support of our customers and partners.

2026-09-14

Our Journey to the 2nd Round Presentation

Elegaiter, the new product currently under development by CiKLux, has completed its Phase 2 face-to-face presentation evaluation, marking the final stage of the '2026 AI Small Business Innovation Support Program'. The program saw intense competition in the initial phase, recording a high 12:1 ratio for the Phase 1 document screening. Having successfully advanced, CiKLux's CEO took the stage as the primary presenter for the Phase 2 evaluation, presenting the company's technical capabilities as a specialized clinical research organization (CRO) alongside the market potential of the product. The presentation was delivered strictly within the 10-minute time limit. While the panel of judges raised highly technical and sharp questions, the session served as an opportunity to objectively demonstrate Elegaiter’s technological value and distinct advantages through clear, expertise-backed responses. Members of the internal team present at the site were able to reconfirm the core competitiveness and value of our product. Upon final selection for this support program, the secured resources will be fully allocated toward advancing Elegaiter’s service capabilities and executing aggressive marketing campaigns for market entry. This initiative is expected to elevate the product as a driver of digital transformation in the clinical trial market while significantly broadening touchpoints with partners and clients. Having successfully navigated both the competitive document screening and the critical face-to-face evaluation, the entire team now awaits a positive final outcome. We appreciate the continued interest and support from our employees and partners as Elegaiter prepares for its next milestone. Further updates will be shared as soon as the final results are announced.

Blog Insights

2026-08-27

Contact

43-14, Gasan digital 2-ro, Geumcheon-gu, Seoul, Republic of Korea

consultant@ciklux.com

Support

Need Help?

User Guide

New to the app? Start here.

View Guide

FAQ

Quickly find solutions to common issues such as Bluetooth connection problems and device errors.

View FAQ

Healthy Steps,Into a Game

Connect WalkingwithDigital Technologyfora More Fun and Healthier Life